Topotecan in Ovarian Cancer

Oncologist - United States
doi 10.1634/theoncologist.2-3-189
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Extending the Platinum‐Free Interval in Recurrent Ovarian Cancer: The Role of Topotecan in Second‐Line Chemotherapy

Oncologist
Cancer ResearchMedicineOncology
1999English

Novel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma Xenografts

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Population Pharmacokinetic Analysis of Topotecan in Pediatric Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2007English

Dasatinib (BMS-35482) Interacts Synergistically With Docetaxel, Gemcitabine, Topotecan, and Doxorubicin in Ovarian Cancer Cells With High SRC Pathway Activation and Protein Expression

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2014English

Successful Local Regional Therapy With Topotecan of Intraperitoneally Growing Human Ovarian Carcinoma Xenografts

British Journal of Cancer
Cancer ResearchOncology
1995English

Ovarian Cancer

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2012English

Ovarian Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Highlights in Ovarian Cancer

Oncologist
Cancer ResearchMedicineOncology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy